WSU-FSCCL
ACC 612
Cell line:
WSU-FSCCL
DSMZ no.:
ACC 612
Species:
human (Homo sapiens)
Cell type:
B cell lymphoma
Origin:
established from the peripheral blood of a 37-year-old white man with low-grade follicular small cleaved cell lymphoma (B-NHL, stage IVB) after chemotherapy and transformation to small cell non-cleaved non-Hodgkin´s lymhoma in 1989; described in the literature to carry t(14;18) and t(8;11) with BCL2 and MYC rearrangements, respectively
Biosafety level:
1
Permissions and restrictions:
DSMZ Cell Culture Data:
Morphology:
Medium:
90% RPMI 1640 + 10% h.i. FBS
Subculture:
seed out at ca. 0.5-1.0 x 106 cells/ml; maintain at 0.25-4.0 x 106 cells/ml; optimal split ratio of 1:3 to 1:5 about 2-3 times a week
Incubation:
at 37 °C with 5% CO2
Doubling time:
ca. 20-30 hours
Harvest:
maximum density at ca. 4.5 x 106 cells/ml
Storage:
frozen with 70% medium, 20% FBS, 10% DMSO
DSMZ Scientific Data:
Mycoplasma:
negative in microbiological culture, PCR assays
Immunology:
CD3 -, CD10 +, CD13 -, CD19 +, CD34 -, CD37 +, CD38 +, CD80 +, CD138 -, HLA-DR +, sm/cyIgG -, sm/cyIgM +, sm/cykappa +, sm/cylambda -; image
Authenticity:
STR analysis according to the global standard ANSI/ATCC ASN-0002.1-2021 (2021) resulted in an authentic STR profile of the reference STR database.
Cytogenetics:
human hyperdiploid karyotype with 4% polyploidy; 47(46-50)<2n>XY, -13, +2mar, add(1)(p34), del(6)(q25), t(8;11)(q24.3;q24), i(13q), t(14;18)(q32;q21); t(14;18) effects IGH-BCL2 rearrangement
Molec. Genetics:
expression of fusion gene IGH-BCL2 (MBR) confirmed by RT-PCR
Viruses:
PCR: EBV -, HBV -, HCV -, HIV-1 -, HIV-2 -, HTLV-1/2 -, MLV -, SMRV -
Supplied as:
| Delivery form | Prices | |
| Frozen culture | 450,- € | |
| Growing culture (please inquire for exact delivery time) | 900,- € | |
| DNA isolated from cell line (25 µg) | 560,- € | |
| DNA isolated from cell line (5 µg) | 140,- € | |
see price list